- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03948230
Hypo-hydration Mood and Cognition
May 10, 2019 updated by: David Benton, Swansea University
Hypo-hydration, Mood and Cognition: the Effect of the Colour and Type of Drink
Recently changes in mood and cognition have been reported following minor reductions in hydration status.
The aim is to explore that such changes in part at least reflect placebo response; therefore the consumption of plain or coloured water will be compared in drinks designed to differ in their ability to rehydrate.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
162 individuals will be subject to a temperature of 30°C for three hours, and mood and cognition monitored.
Randomly on two occasions they will consume no drink or 300ml of plain or red colored water.
In addition they will take a capsule containing sodium chloride or a placebo.
Mood will be monitored using visual analogue scales and a battery of cognitive tests will be completed on three occasions: attention, episodic and working memory, reactions times.
Urine osmolality will be measured at the beginning and end of the study and changes in body mass will be recorded.
Changes in functioning will be related to the nature of the drink and changes in osmolality and body mass.
Study Type
Interventional
Enrollment (Anticipated)
162
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Wales
-
Swansea, Wales, United Kingdom, sa2 8pp
- Recruiting
- Psychology, Swansea University
-
Swansea, Wales, United Kingdom, SA2 8PP
- Recruiting
- Swansea University
-
Contact:
- David Benton, DSc
- Phone Number: ++44 1792 295607
- Email: d.benton@swansea.ac.uk
-
Contact:
- Sara Long, B.Sc.
- Phone Number: ++44 1792 295278
- Email: 444451@swansea.ac.uk
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 30 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion criteria:
- 18 to 30 years
- Non-smokers
- BMI < 30
- By self-report in good health
- Not taking medication for any psychological or other health disorder.
Exclusion Criteria:
- Do not meet inclusion criteria
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Sodium chloride / Water
300mg sodium chloride consumed in a capsule on two occasions with 300ml water
|
Drinks with and without a salt containing capsule
|
|
Active Comparator: Sodium chloride / no water
300 mg sodium chloride consumed
|
Drinks with and without a salt containing capsule
|
|
Active Comparator: Sodium chloride / colored water
300mg sodium chloride consumed in a capsule on two occasions with 300ml coloured water
|
Drinks with and without a salt containing capsule
|
|
Placebo Comparator: Placebo / water
Placebo consumed in a capsule on two occasions with 300ml water
|
Drinks with and without a salt containing capsule
|
|
Placebo Comparator: Placebo / no water
Placebo capsule consumed
|
Drinks with and without a salt containing capsule
|
|
Placebo Comparator: Placebo / coloured water
Placebo consumed in a capsule on two occasions with 300ml colored water
|
Drinks with and without a salt containing capsule
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mood rating: agreeable / hostile
Time Frame: Changes from baseline after 90 and 180 minutes
|
A hundred millimetre lines will be anchored with the words agreeable/hostile and the subject will rate their mood by marking the line.. My measuring in millimetres a score between 0 and 100 will result with a higher score indicating a more positive mood.
|
Changes from baseline after 90 and 180 minutes
|
|
Mood rating: confused / clearheaded
Time Frame: Changes from baseline after 90 and 180 minutes
|
A hundred millimetre lines will be anchored with the words confused / clearheaded and the subject will rate their mood by marking the line.. My measuring in millimetres a score between 0 and 100 will result with a higher score indicating a more positive mood.
|
Changes from baseline after 90 and 180 minutes
|
|
Mood rating: composed / anxious
Time Frame: Changes from baseline after 90 and 180 minutes
|
A hundred millimetre lines will be anchored with the words composed / anxious and the subject will rate their mood by marking the line.. My measuring in millimetres a score between 0 and 100 will result with a higher score indicating a more positive mood.
|
Changes from baseline after 90 and 180 minutes
|
|
Mood rating: depressed / elated
Time Frame: Changes from baseline after 90 and 180 minutes
|
A hundred millimetre lines will be anchored with the words depressed / elated and the subject will rate their mood by marking the line.. My measuring in millimetres a score between 0 and 100 will result with a higher score indicating a more positive mood.
|
Changes from baseline after 90 and 180 minutes
|
|
Mood rating: tired / energetic
Time Frame: Changes from baseline after 90 and 180 minutes
|
A hundred millimetre lines will be anchored with the words tired / energetic and the subject will rate their mood by marking the line.. My measuring in millimetres a score between 0 and 100 will result with a higher score indicating a more positive mood.
|
Changes from baseline after 90 and 180 minutes
|
|
Mood rating: confident / unsure
Time Frame: Changes from baseline after 90 and 180 minutes
|
A hundred millimetre lines will be anchored with the words confident / unsure and the subject will rate their mood by marking the line.. My measuring in millimetres a score between 0 and 100 will result with a higher score indicating a more positive mood.
|
Changes from baseline after 90 and 180 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Episodic memory
Time Frame: Changes from baseline after 90 and 180 minutes
|
A list of 30 words will be presented after which the subject writes down as many as can be recalled.
The resulting score will vary from 0-30.
|
Changes from baseline after 90 and 180 minutes
|
|
Serial Sevens; test of working memory
Time Frame: Changes from baseline after 90 and 180 minutes
|
28 numbers each of three digits will be presented and the subject indicates whether a subsequent number was exactly seven less.
The measure reported is the response time in milli-seconds taken to respond
|
Changes from baseline after 90 and 180 minutes
|
|
Attention: Arrow Flankers
Time Frame: Changes from baseline after 90 and 180 minutes
|
A series is presented that can be >>>>> or >><>> and the subject has to indicated whether the middle symbol points to the right or left.
The measure reported is the time taken to respond in milli-seconds
|
Changes from baseline after 90 and 180 minutes
|
|
Reaction times
Time Frame: Changes from baseline after 90 and 180 minutes
|
The time to press a button under an illuminated light was recorded in milli-seconds when there was 1, 2, 4, or 8 possible lamps that could be lit.
20 trials were performed with each of the four number of lights.
|
Changes from baseline after 90 and 180 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: David Benton, DSc, Professor of Psychology
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2018
Primary Completion (Anticipated)
July 31, 2019
Study Completion (Anticipated)
July 31, 2019
Study Registration Dates
First Submitted
May 8, 2019
First Submitted That Met QC Criteria
May 10, 2019
First Posted (Actual)
May 13, 2019
Study Record Updates
Last Update Posted (Actual)
May 13, 2019
Last Update Submitted That Met QC Criteria
May 10, 2019
Last Verified
May 1, 2019
More Information
Terms related to this study
Other Study ID Numbers
- DB-0519
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cognitive Change
-
University Ramon LlullAinhoa Nieto Guisado; Mònica Solana-TramuntUnknownCognitive Change | Proprioception Change | Balance ChangeSpain
-
Applied Science & Performance InstituteCompletedCognitive Change | Mood Change | Mental ProcessesUnited States
-
National Council of Scientific and Technical Research...CompletedSleep | Cognitive Change | Mood Change | CreativityArgentina
-
Mentage LLCNot yet recruitingCognitive Change | Aging | Healthy Aging | Health Behavior | Primary Care | Cognitive Wellness | Age-Related Cognitive Change
-
Heilongjiang Feihe Dairy Co. Ltd.CompletedCognitive ChangeChina
-
University of MiamiMcKnight Brain Research FoundationCompleted
-
University of Wisconsin, MadisonNational Institute on Aging (NIA); University of California, Irvine; University...Completed
-
Tufts UniversityCompleted
-
Northeastern UniversityNational Institute on Aging (NIA); University of California, RiversideCompletedCognitive ChangeUnited States
-
Western University, CanadaInteraXon, Inc.; Cambridge Brain SciencesCompletedCognitive ChangeCanada
Clinical Trials on Salt with / without water
-
Pfizer's Upjohn has merged with Mylan to form Viatris...Completed
-
Rambam Health Care CampusCompleted
-
Edith Cowan UniversityFlinders University; The University of Western AustraliaCompleted
-
University of BrasiliaConselho Nacional de Desenvolvimento Científico e Tecnológico; MRC Human Nutrition...Completed
-
University of North Carolina, Chapel HillCompleted
-
HK inno.N CorporationCompletedHealthyKorea, Republic of
-
Liita Care ApSUnknownObstructive Airway DiseasesDenmark
-
Liita Care ApSSuspendedCOPD | Copd BronchitisDenmark
-
Hacettepe UniversityCompletedRheumatoid Arthritis - RheumatismTurkey
-
Swiss Federal Institute of TechnologyUniversity of ZurichCompleted